BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2289729)

  • 1. [Morphology of Alzheimer disease].
    Braak H; Braak E
    Fortschr Med; 1990 Nov; 108(33):621-4. PubMed ID: 2289729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphological changes in the human cerebral cortex in dementia].
    Braak H; Braak E
    J Hirnforsch; 1991; 32(3):277-82. PubMed ID: 1779131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer changes in nondemented patients younger than sixty-five: possible early stages of Alzheimer's disease and senile dementia of Alzheimer type.
    Ulrich J
    Ann Neurol; 1985 Mar; 17(3):273-7. PubMed ID: 3994315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Brain lesions, pathogenic and etiologic hypotheses of Alzheimer's disease].
    Dessi F; Colle MA; Hauw JJ; Duyckaerts C
    Rev Prat; 1998 Nov; 48(17):1873-8. PubMed ID: 9854388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuropathological changes associated with normal brain aging.
    Hof PR; Glannakopoulos P; Bouras C
    Histol Histopathol; 1996 Oct; 11(4):1075-88. PubMed ID: 8930649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of altered hippocampal neurons and axons immunoreactive with antisera against neuropeptide Y in Alzheimer's-type dementia.
    Chan-Palay V; Lang W; Haesler U; Köhler C; Yasargil G
    J Comp Neurol; 1986 Jun; 248(3):376-94. PubMed ID: 3522663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
    Papasozomenos SC
    Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasticity and neurotransmitter receptor changes in Alzheimer's disease and experimental cortical infarcts.
    Zilles K; Qü M; Schleicher A; Schroeter M; Kraemer M; Witte OW
    Arzneimittelforschung; 1995 Mar; 45(3A):361-6. PubMed ID: 7763327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular vulnerability in brain aging and Alzheimer's disease. Clinical correlates and molecular background.
    Giannakopoulos P; Gold G; Michel JP; Bouras C
    Ann Med Interne (Paris); 1998 Jun; 149(4):187-91. PubMed ID: 11490545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
    Ikeda S; Allsop D; Glenner GG
    Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody.
    Ikeda S; Allsop D; Glenner GG
    Lab Invest; 1989 Jan; 60(1):113-22. PubMed ID: 2642985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The second layer neurones of the entorhinal cortex and the perforant path in physiological ageing and Alzheimer's disease.
    Moryś J; Sadowski M; Barcikowska M; Maciejewska B; Narkiewicz O
    Acta Neurobiol Exp (Wars); 1994; 54(1):47-53. PubMed ID: 8023713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perforant pathway changes and the memory impairment of Alzheimer's disease.
    Hyman BT; Van Hoesen GW; Kromer LJ; Damasio AR
    Ann Neurol; 1986 Oct; 20(4):472-81. PubMed ID: 3789663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.
    Snow AD; Mar H; Nochlin D; Kimata K; Kato M; Suzuki S; Hassell J; Wight TN
    Am J Pathol; 1988 Dec; 133(3):456-63. PubMed ID: 2974240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alzheimer's disease: lesions and their progression].
    Duyckaerts C; Colle MA; Delatour B; Hauw JJ
    Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphologic and molecular neuropathology of Alzheimer's disease].
    Duyckaerts C; Panchal M; Delatour B; Potier MC
    Ann Pharm Fr; 2009 Mar; 67(2):127-35. PubMed ID: 19298896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of synaptic density in the entorhinal cortex in Alzheimer's disease.
    Scheff SW; Sparks L; Price DA
    Ann Neurol; 1993 Sep; 34(3):356-61. PubMed ID: 8363352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease.
    Hyman BT; Kromer LJ; Van Hoesen GW
    Ann Neurol; 1987 Mar; 21(3):259-67. PubMed ID: 3606033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
    Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An Alzheimer's disease case showing recurrent subcortical hemorrhage: an autopsy findings with immunohistochemical studies of cerebral amyloid deposits].
    Maruyama K; Ikeda S; Odajima N; Yanagisawa N
    Rinsho Shinkeigaku; 1989 Jul; 29(7):936-9. PubMed ID: 2805520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.